Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rubens Camargo Siqueira is a Brazilian clinical research entity and specialized ophthalmology center focused on regenerative medicine. Led by Dr. Rubens Camargo Siqueira, the organization is recognized for its pioneering work in using autologous bone marrow-derived stem cells to treat degenerative retinal diseases. Their research portfolio includes clinical trials for conditions such as retinitis pigmentosa, Stargardt disease, and age-related macular degeneration. The entity provides both advanced diagnostic services and experimental cell-based therapies aimed at restoring or preserving vision. Based in São José do Rio Preto, it serves as a key center for ocular stem cell research in Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rubens Camargo Siqueira.